Clinical Trial Update: Amonafide in Combination With Cytarabine in Secondary AML [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating amonafide in combination with cytarabine for secondary acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Amonafide (amonafide)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Xanthus Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED